| VOC in Breath Samples for the Diagnosis of IPA (NCT05982912) | Rambam Health Care Campus | 2022-03-03 |
| Diagnosis of Invasive Pulmonary Aspergillosis, Specific Testing in Bronchial Secretions Versus Bronchoalveolar Fluid (NCT04848831) | Universitätsklinikum Hamburg-Eppendorf | 2021-06-01 |
| Prevalence of Influenza RelAted Invasive Aspergillosis (NCT04172610) | Karolinska University Hospital | 2019-12-02 |
| Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study) (NCT04267497) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2019-10-18 |
| Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis (NCT03672292) | Scynexis, Inc. | 2019-01-22 |
| Influenza Associated Aspergillosis In-depth Investigation (NCT03748069) | Universitaire Ziekenhuizen KU Leuven | 2019-01-18 |
| VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults (NCT03327727) | Vical | 2018-02-20 |
| Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (NCT03059992) | Scynexis, Inc. | 2017-04-01 |
| Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients (NCT06654076) | Guangzhou Institute of Respiratory Disease | 2015-01-01 |
| Voriconazole for IPA in Chinese Patients With COPD (NCT02234739) | Red Cross Hospital, Hangzhou, China | 2014-10-01 |
| CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients (NCT02100761) | dingshifang | 2014-06-01 |
| A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) (NCT01782131) | Merck Sharp & Dohme LLC | 2013-09-25 |
| Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study (NCT02058316) | Medical University of Graz | 2013-02-01 |
| Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects (NCT01188759) | Pfizer | 2012-05-01 |
| Efficacy and Safety of Caspofungin for Invasive Pulmonary Aspergillosis Underlying Chronic Obstructive Pulmonary Disease (NCT01499433) | The First Affiliated Hospital of Guangzhou Medical University | 2012-01-01 |
| Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia (NCT01615809) | Fundació Sant Joan de Déu | 2011-10-01 |
| Evaluation of Exhaled Breath Condensate in the Diagnosis of Invasive Pulmonary Aspergillosis (NCT01247142) | Universitaire Ziekenhuizen KU Leuven | 2011-01-01 |
| Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis (NCT00923832) | National Cancer Institute (NCI) | 2009-03-30 |
| Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation (NCT00986713) | Capital Medical University | 2008-06-01 |
| Prophylaxis of Fungal Invasive Infections in Leukemia (NCT00501098) | Northern Italy Leukemia Group | 2007-01-01 |
| Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis (NCT05897294) | TFF Pharmaceuticals, Inc. | |